SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-109256
Filing Date
2023-10-16
Accepted
2023-10-16 08:51:49
Documents
13
Period of Report
2023-10-16
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2328502d1_8k.htm   iXBRL 8-K 25904
2 EXHIBIT 99.1 tm2328502d1_ex99-1.htm EX-99.1 14344
  Complete submission text file 0001104659-23-109256.txt   219066

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA sls-20231016.xsd EX-101.SCH 3042
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE sls-20231016_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sls-20231016_pre.xml EX-101.PRE 22378
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2328502d1_8k_htm.xml XML 3320
Mailing Address 7 TIMES SQUARE SUITE 2503 NEW YORK NY 10036
Business Address 7 TIMES SQUARE SUITE 2503 NEW YORK NY 10036 6462005278
SELLAS Life Sciences Group, Inc. (Filer) CIK: 0001390478 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33958 | Film No.: 231326337
SIC: 2834 Pharmaceutical Preparations